Axios @axios
A new Seattle-based company is developing an at-home kit that enables users to collect saliva and finger-prick blood samples, which the company can then analyze to measure hormone baseline levels and assess genetic risks for blood clots and depression. https://t.co/wiWZT3b0HQ — PolitiTweet.org